Citation Impact
Citing Papers
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Effect of Captopril on Mortality and Morbidity in Patients with Left Ventricular Dysfunction after Myocardial Infarction
1992 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Oral Anticoagulant Therapy in Patients With Coronary Artery Disease: A Meta-analysis
1999
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial
1998 Standout
Oral anticoagulants in patients with coronary artery disease
2003
Erectile Dysfunction
2000 Standout
Prognosis and Management after a First Myocardial Infarction
1990
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
1996 Standout
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Meta-analysis in epidemiology, with special reference to studies of the association between exposure to environmental tobacco smoke and lung cancer: A critique
1991
Platelet Activation and Atherothrombosis
2007 Standout
GRADE guidelines: 3. Rating the quality of evidence
2011 Standout
Anticoagulant-related bleeding: Clinical epidemiology, prediction, and prevention
1993 Standout
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration
2009 Standout
Dabigatran versus Warfarin in Patients with Atrial Fibrillation
2009 Standout
Intercalation and delamination of layered carbides and carbonitrides
2013 Standout
The Hazards of Scoring the Quality of Clinical Trials for Meta-analysis
1999 Standout
Warfarin, Aspirin, or Both after Myocardial Infarction
2002
Clinical Implications of Prostaglandin and Thromboxane A2Formation
1988
Regulatory Functions of the Vascular Endothelium
1990 StandoutNobel
Prophylactic aspirin and risk of peptic ulcer bleeding
1995
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
2017 Standout
Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein Cholesterol
1999 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment
2008
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Hemorrhagic Complications of Anticoagulant Treatment
1998
Hemorrhagic Complications of Anticoagulant Treatment
2001 Standout
Low-Dose Aspirin Therapy for Chronic Stable Angina
1991
External validity of randomised controlled trials: “To whom do the results of this trial apply?”
2005 Standout
Hemorrhagic Complications of Anticoagulant Treatment
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Bioinspired structural materials
2014 Standout
Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin
1998
Prospects of Colloidal Nanocrystals for Electronic and Optoelectronic Applications
2009 Standout
Aspirin and other antiplatelet agents in the secondary and primary prevention of cardiovascular disease.
1989
Secondary Prevention for Ischemic Heart Disease
1997
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Ultrastrong and Stiff Layered Polymer Nanocomposites
2007 StandoutScience
Warum Pentose‐ und nicht Hexose‐Nucleinsäuren??. Teil II. Oligonucleotide aus 2′,3′‐Dideoxy‐β‐D ‐glucopyranosyl‐Bausteinen (‘Homo‐DNS’): Herstellung.
1992
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Flexible and conductive MXene films and nanocomposites with high capacitance
2014 Standout
Azole-Based Energetic Salts
2011 Standout
Potential therapeutic applications of aspirin and other cyclo‐oxygenase inhibitors.
1980
Inhibition of Endothelial Regeneration by Type-Beta Transforming Growth Factor from Platelets
1986 StandoutScience
Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic.
1994 Standout
Aspirin after myocardial infarction
1989
Review papers : The statistical basis of meta-analysis
1993
The gastrointestinal toxicity of aspirin: an overview of randomised controlled trials.
1993
Aspirin and Other Platelet-Active Drugs
1992
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1989
Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty
1987
Nonnarcotic Analgesic Use and the Risk of Hypertension in US Women
2002
Management of Massive and Submassive Pulmonary Embolism, Iliofemoral Deep Vein Thrombosis, and Chronic Thromboembolic Pulmonary Hypertension
2011 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Hemorrhagic Complications of Anticoagulant Treatment
1992
A Field Guide to Foldamers
2001 Standout
Blood pressure, stroke, and coronary heart disease
1990 Standout
Hemorrhagic Complications of Long-term Anticoagulant Therapy
1986
The Effect of Cigarette Smoking on Penile Erection
1987
Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable Angina
1983
Clinical Aspects of Platelet Inhibitors and Thrombus Formation
2007
COAGULATION DISORDERS IN CANCER
1996
The Vanilloid Receptor: A Molecular Gateway to the Pain Pathway
2001 StandoutNobel
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Global Burden of Cardiovascular Diseases
2001 Standout
Coronary Plaque Disruption
1995 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration
2001 Standout
Bleeding during acetylsalicylic acid and anticoagulant therapy in patients with reduced platelet reactivity after aortic valve replacement
1980
Hemorrhagic Complications of Anticoagulant Treatment
1995
Halloysite Clay Nanotubes for Loading and Sustained Release of Functional Compounds
2015 Standout
Composites Reinforced in Three Dimensions by Using Low Magnetic Fields
2012 StandoutScience
Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty
1994 Standout
Secondary prevention after myocardial infarction: A review of long-term trials
1982
First Actinide Complexes of the Nitrogen-Containing Ligands Dinitramide (N(NO2)2−), 4,5-Dicyano-1,2,3-triazolate (C4N5−), and Dicyanamide (N(CN)2−)
2010
Aspirin and other platelet active drugs. Relationship among dose, effectiveness, and side effects.
1989
The randomized clinical trial: bias in analysis.
1981
Meta-analysis in clinical trials
1986 Standout
Vessel injury, platelet adherence, and platelet survival.
1983
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of E. Walter being referenced
PENICILLIN-INDUCED COAGULATION DISORDER
1976
Intra- und intermolekulare Vernetzung von Polyvinylalkohol mit Dialdehyden
1980
Secondary Prevention of Myocardial Infarction: a Comparison of Acetylsalicylic Acid, Placebo and Phenprocoumon
1980
Secondary Prevention of Myocardial Infarction Comparison of Acetylsalicylic Acid, Phenprocoumon and Placebo
1979
Schwingungsspektren und Kraftkonstanten der Übergangsreihen OP(N(CH3)2)3– OP(CH3)3und SP(N(CH3)2)3– SP(CH3)3
1975
German-Austrian Multicenter two Years Prospective study on the Prevention of Secondary Myocardial Infarction by ASA in Comparison of Phenprocoumon and Placebo
1977
The German-Austrian aspirin trial: a comparison of acetylsalicylic acid, placebo and phenprocoumon in secondary prevention of myocardial infarction. On behalf of the German-Austrian Study Group.
1980
Does chronic aspirin treatment increase blood pressure in man?
1981
Bakteriochlorophyll aGg und Bakteriophäophytin aP in den photosynthetischen Reaktionszentren von rhodospirillum rubrum G‐9+
1979
Evaluation of smoking-induced effects on sympathetic, hemodynamic and metabolic variables with respect to plasma nicotine and COHb levels
1979